跳至主要内容
临床试验/NCT01742520
NCT01742520Unknown不适用

Its an Interventional Study That Will Evaluate the Effect of Different Doses of Sucrose 24% on Neurodevelopmental Outcome of Preterm Infants

Sheba Medical Center1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2013年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
90
试验地点
1
主要终点
neurodevelopmental outcomes

研究概览

简要总结

The purpose of this study is to determine the effect of sucrose 24% for pain prevention on preterm infants. Our hypothesis is that repeated doses of sucrose 24%, given prior to painful procedure,do not impair neurodevelopmental outcomes of preterm infants

详细描述

preterm infants born at 27-33 weeks gestational age at Sheba Medical Center will be recruited for this study. Prior to invasive procedure infants will be treated with pacifier and swaddling as recommended by the American Academy of Pediatrics and Canadian Pediatric Society.

Group 1.Will be treated with Sucrose 24% 0.1-0.5ml on the anterior pat of the tongue 1-3 min prior to invasive procedure.

Group 2. Similar to group 1 but breast milk or formula will replace Sucrose.

Number of invasive procedures/day will be documented

General Movements by Prechtel will be used for developmental assessment at 2,4,6 weeks after birth and at 14-16 weeks corrected age

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
27 Weeks 至 33 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • preterm infants born at SMC

排除标准

  • need for intubation
  • need for sedation
  • abnormal head ultrasound
  • genetic abnormalities
  • necrotizing enterocolitis
  • other painful conditions other than routine blood exams

研究组 & 干预措施

Formula or Breast Milk

Active Comparator

Breast milk or formula prior to every painful procedure.

干预措施: Formula or breast milk (Drug)

Multiple doses of sucrose

Active Comparator

Infants in this group will be treated with Sucrose 24% 0.5-1ml on the anterior pat of the tongue 1-3min prior to every invasive procedure

干预措施: multiple doses of sucrose (Drug)

结局指标

主要结局

neurodevelopmental outcomes

时间窗: at 6 month corrected age

Griffith mental developmental scaled (gross and fine motor, language, performance, social) and General movements by Prechtel

次要结局

  • neurodevelopment(at 15 weeks corrected age)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr. Iris Morag

Staff Neonatologist

Sheba Medical Center

研究点 (1)

Loading locations...

相似试验